Worth reading
38Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
222
Hundred millions of yenWording
Conditional
How definitive the wording is.Contents of this document
Summary of Q&AFull fiscal year ended May 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales222 Hundred millions of yen+3.4%
Operating profit3.1 Hundred millions of yen+6.3%
Net incomeLoss for the period (figure is Not disclosed)
Results for the three months of the current quarterThe company stated that the number of active users increased in the fourth quarter. Financial figures for the three-month period alone are Not disclosed
Full-year earnings forecast
Fiscal Period CoveredFiscal year ending May 2027
Net Sales
265 Hundred millions of yen
EBITDA
17 Hundred millions of yen
Operating profit
10.5 Hundred millions of yen
Ordinary income
10 Hundred millions of yen
Net income for the current fiscal year
5.5 Hundred millions of yen
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Results for the fiscal year ended May 2026 were broadly in line with expectationsKey points of the Q&AKey questions raised by investors at the briefing and the company's answers
- Factors behind the increase in active users: growth in SOKUYAKU Benefit, including its introduction in school trip plans
- Confidence in the operating income plan for the fiscal year ending May 2027: the company explained that confidence is high because it reviewed the internal and external environment for all businesses and built up the figures accordingly
- Value of receiving the Japan Resilience Award: the company explained that recognition as medical infrastructure by the Japanese government increased trust and reassurance, providing a foundation for business growth
- Impact of legal reforms: the company explained that new applications and business opportunities would expand, including online medical consultations at post offices and community centers and the collection of over-the-counter medicines at convenience stores
- Assessment of the change in shareholder benefits: the company explained that the number of new shareholders had increased and that it would aim to improve trading volume and the share price going forward
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
The breakdown by factor, including figures, is Not disclosed. The company explained that growth in the number of SOKUYAKU transactions and Benefit subscribers, high-margin projects in marketing support and logistics, and advertising investments for the following fiscal year contributed to results
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
The company explained that its outlook assumes growth in the SOKUYAKU business, disaster preparedness and national resilience policies, legal reforms, and broader adoption by local governments and medical institutions. Numerical assumptions are Not disclosedNew initiatives
- Launch of a disaster preparedness and medical solution for local governments
- A new SOKUYAKU feature that allows users to search for and book clinics based on their preferred time
- Launch of an in-person medication counseling feature
- Participation in Tokyo's Children's Smile Movement
Key KPIsA metric the company considers important as a management benchmark.
- Number of SOKUYAKU users250 Year on year %Year on year against the same period last year+250.0%
- SOKUYAKU medical institution network4,100 More than medical institutions
- SOKUYAKU fourth-quarter active usersIncreased
Segment results
- Medical Care Sales businessNet Sales52.83 Hundred millions of yenEBITDA5.28 Hundred millions of yen
- Healthcare Sales businessNet Sales53.83 Hundred millions of yenEBITDA3.97 Hundred millions of yen
- Healthcare Marketing businessNet Sales115.68 Hundred millions of yenEBITDA4 Hundred millions of yenYear on year against the same period last yearHigher revenue and profits
| Item | Details |
|---|---|
| Document type | Summary of Q&A |
| Fiscal Period Covered | Full fiscal year ended May 2026 |
| Net Sales | 222 Hundred millions of yen (YoY +3.4%) |
| Operating profit | 3.1 Hundred millions of yen (YoY +6.3%) |
| Net income | Loss for the period (figure is Not disclosed) |
| Results for the three months of the current quarter | The company stated that the number of active users increased in the fourth quarter. Financial figures for the three-month period alone are Not disclosed |
| Full-year earnings forecast | Fiscal Period Covered Fiscal year ending May 2027 / Net Sales 265 Hundred millions of yen / EBITDA 17 Hundred millions of yen / Operating profit 10.5 Hundred millions of yen / Ordinary income 10 Hundred millions of yen / Net income for the current fiscal year 5.5 Hundred millions of yen |
| Self-assessment against the plan | Results for the fiscal year ended May 2026 were broadly in line with expectations |
| Segment results | Segment Medical Care Sales business / Net Sales 52.83 Hundred millions of yen / EBITDA 5.28 Hundred millions of yen / Year on year against the same period last year Not disclosed, Segment Healthcare Sales business / Net Sales 53.83 Hundred millions of yen / EBITDA 3.97 Hundred millions of yen / Year on year against the same period last year Not disclosed, Segment Healthcare Marketing business / Net Sales 115.68 Hundred millions of yen / EBITDA 4 Hundred millions of yen / Year on year against the same period last year Higher revenue and profits |
| Breakdown of Factors Affecting the Change | The breakdown by factor, including figures, is Not disclosed. The company explained that growth in the number of SOKUYAKU transactions and Benefit subscribers, high-margin projects in marketing support and logistics, and advertising investments for the following fiscal year contributed to results |
| Key KPIs | Indicator name Number of SOKUYAKU users / Value 250 Year on year (%) / Year on year against the same period last year 250 Year on year (%), Indicator name SOKUYAKU medical institution network / Value 4,100 More than medical institutions / Year on year against the same period last year Not disclosed, Indicator name SOKUYAKU fourth-quarter active users / Value Increased / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | The company explained that its outlook assumes growth in the SOKUYAKU business, disaster preparedness and national resilience policies, legal reforms, and broader adoption by local governments and medical institutions. Numerical assumptions are Not disclosed |
| Key points of the Q&A | Factors behind the increase in active users: growth in SOKUYAKU Benefit, including its introduction in school trip plans, Confidence in the operating income plan for the fiscal year ending May 2027: the company explained that confidence is high because it reviewed the internal and external environment for all businesses and built up the figures accordingly, Value of receiving the Japan Resilience Award: the company explained that recognition as medical infrastructure by the Japanese government increased trust and reassurance, providing a foundation for business growth, Impact of legal reforms: the company explained that new applications and business opportunities would expand, including online medical consultations at post offices and community centers and the collection of over-the-counter medicines at convenience stores, Assessment of the change in shareholder benefits: the company explained that the number of new shareholders had increased and that it would aim to improve trading volume and the share price going forward |
| New initiatives | Launch of a disaster preparedness and medical solution for local governments, A new SOKUYAKU feature that allows users to search for and book clinics based on their preferred time, Launch of an in-person medication counseling feature, Participation in Tokyo's Children's Smile Movement |
Items this document does not state (17)
Ordinary incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesProgress against full-year forecastUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / Share
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profit margins improved from the second half as a result of measures implemented in the first half. In the fourth quarter, the company made business investments for growth from the following fiscal year onward while also recovering its investments. In addition, growth in the number of SOKUYAKU transactions and Benefit subscribers, along with high-margin projects in the marketing support and logistics businesses, contributed to results.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.